Morgan Stanley downgrades Accenture to Equal-Weight, cuts target to $177

0 min read     Updated on 15 Jun 2026, 11:01 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Morgan Stanley analyst James Faucette downgraded Accenture from Overweight to Equal-Weight and lowered the price target to $177 from $240.

powered bylight_fuzz_icon
43090264

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst James Faucette downgraded Accenture from Overweight to Equal-Weight, reducing the price target to $177 from $240. The adjustment reflects a revised outlook on the stock's performance potential.

Rating and Target Changes

The downgrade moves Accenture from a bullish rating to a neutral stance. The significant reduction in the price target suggests a lower expected upside compared to previous estimates.

Metric Previous New
Rating Overweight Equal-Weight
Price Target $240 $177

What specific factors led to the significant reduction in the price target?

How might this downgrade impact investor sentiment toward the IT consulting sector?

What are the key risks Accenture faces in the current market environment?

like15
dislike

JP Morgan maintains Overweight on Accenture, cuts target to $201

0 min read     Updated on 08 Jun 2026, 11:10 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

JP Morgan analyst Tien-Tsin Huang maintained an Overweight rating on Accenture but lowered the price target to $201 from $247, signaling a revised valuation outlook.

powered bylight_fuzz_icon
42486002

*this image is generated using AI for illustrative purposes only.

JP Morgan analyst Tien-Tsin Huang has maintained an Overweight rating on Accenture while lowering the price target to $201 from $247. The revised target indicates a shift in valuation expectations despite the positive stance on the stock.

Rating and Target Details

The research note highlights the following changes:

  • Rating: Overweight (maintained)
  • Previous Price Target: $247
  • New Price Target: $201

The decision to lower the price target suggests a recalibration of the stock's potential upside, although the analyst continues to recommend overweighting the position relative to its benchmark.

What specific factors led to the $46 price target reduction despite the maintained Overweight rating?

How might this valuation recalibration influence investor sentiment towards Accenture in the short term?

What are the potential market conditions or industry trends that could drive Accenture's stock back toward its previous target?

like16
dislike

More News on Accenture PLC